Table 4 summarizes the components of the original 5As framework applied to obesity care using GLP-1 treatment
To date, clinical trials have shown that at least three GLP-1RAsexenatide, liraglutide, and lixisenatidecan improve motor deficits when used as adjunctive therapy in PD patients, and GLP-1RA liraglutide can improve cognitive function in AD patients
Episode: 264 If you are using a GLP-1 medication and noticing hair shedding, brittle nails, or dull, dry skin, your body is signaling a nutrient gap
With the advent of several new incretin combination drugs, future research must focus on selecting the right patient for the right incretin combination
This is considered at least partially responsible for the fact that most attempts to lose weight through dieting fail (Stalonas and Kirschenbaum, 1985